In some countries, this medicine may only be approved for veterinary use.
In the US, Carmustine (carmustine systemic) is a member of the drug class alkylating agents and is used to treat Brain Tumor, Glioblastoma Multiforme, Hodgkin's Lymphoma, Malignant Glioma, Multiple Myeloma and Non-Hodgkin's Lymphoma.
US matches:
- Carmustine
- Carmustine Implant Wafer
- Carmustine Implantation
- Carmustine Intravenous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01AD01
CAS registry number (Chemical Abstracts Service)
0000154-93-8
Chemical Formula
C5-H9-Cl2-N3-O2
Molecular Weight
214
Therapeutic Category
Antineoplastic agent, alkylating agent
Chemical Name
Urea, N,N'-bis(2-chloroethyl)-N-nitroso-
Foreign Names
- Carmustinum (Latin)
- Carmustin (German)
- Carmustine (French)
- Carmustina (Spanish)
Generic Names
- Carmustina (OS: DCIT)
- Carmustine (OS: BAN, USAN, DCF)
- BCNU (IS)
- NSC 409962 (IS)
- SK 27702 (IS)
- Carmustin (PH: Ph. Eur. 6)
- Carmustine (PH: BP 2010, Ph. Eur. 6)
- Carmustinum (PH: Ph. Eur. 6)
Brand Names
- BiCNU
Bristol-Myers Squibb, United Arab Emirates; Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Bosnia & Herzegowina; Bristol-Myers Squibb, Bahrain; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Cote D'ivoire; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Algeria; Bristol-Myers Squibb, Egypt; Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Iraq; Bristol-Myers Squibb, Iran; Bristol-Myers Squibb, Jordan; Bristol-Myers Squibb, Kuwait; Bristol-Myers Squibb, Lebanon; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Philippines; Bristol-Myers Squibb, Qatar; Bristol-Myers Squibb, Saudi Arabia; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, Syria; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Yemen; Bristol-Myers Squibb, South Africa; IFET, Greece - BiCNU (veterinary use)
Bristol-Myers Squibb, United Kingdom - Carmubris
Bristol-Myers Squibb, Austria; IFET, Greece - Gliadel Wafer
Medison, Israel; MGI, United States - Gliadel
Archimedes, United Kingdom; Dompé, Italy; Eisai, United States; Generics, Greece; Orphan, Australia; Pensa, Spain; Pharmaplan, South Africa; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal - Nitrumon
Almirall, Luxembourg
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment